Free Trial

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Calumet Specialty Products Partners logo with Energy background

Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six ratings firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $18.50.

Several research analysts recently commented on the company. The Goldman Sachs Group reduced their price target on Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Wednesday, April 30th. HC Wainwright reissued a "buy" rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and decreased their target price for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Bank of America began coverage on shares of Calumet Specialty Products Partners in a research report on Tuesday, May 13th. They set a "buy" rating and a $15.00 price target on the stock. Finally, UBS Group upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and cut their price target for the company from $15.00 to $12.00 in a research note on Monday, March 17th.

View Our Latest Stock Analysis on Calumet Specialty Products Partners

Calumet Specialty Products Partners Stock Down 2.0%

CLMT traded down $0.27 during trading hours on Monday, hitting $13.17. 536,368 shares of the company's stock were exchanged, compared to its average volume of 935,128. The stock has a market cap of $1.14 billion, a price-to-earnings ratio of -4.77 and a beta of 0.91. Calumet Specialty Products Partners has a 1-year low of $7.68 and a 1-year high of $25.29. The stock's 50-day moving average is $11.75 and its two-hundred day moving average is $15.55.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. Calumet Specialty Products Partners's revenue was down 1.2% on a year-over-year basis. During the same period last year, the company posted ($0.51) EPS. On average, equities research analysts anticipate that Calumet Specialty Products Partners will post -3.02 EPS for the current year.

Insiders Place Their Bets

In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 100,000 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $13.17, for a total value of $1,317,000.00. Following the transaction, the director now directly owns 1,084,589 shares of the company's stock, valued at $14,284,037.13. This represents a 8.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction that occurred on Tuesday, April 22nd. The stock was sold at an average price of $9.29, for a total transaction of $33,954.95. Following the sale, the director now owns 283,652 shares of the company's stock, valued at $2,635,127.08. This trade represents a 1.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 107,310 shares of company stock valued at $1,398,031 over the last ninety days. 4.07% of the stock is currently owned by company insiders.

Calumet Specialty Products Partners Company Profile

(Get Free Report

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Featured Articles

Analyst Recommendations for Calumet Specialty Products Partners (NASDAQ:CLMT)

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines